Flufenamic acid inhibition of PGE2 production by rectal mucosa in ulcerative colitis.
D003093:Colitis, Ulcerative / Q000378:metabolism*; D046508:Culture Techniques; D004353:Drug Evaluation, Preclinical; D005439:Flufenamic Acid / Q000494:pharmacology*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D008775:Methylprednisolone / Q000494:pharmacology; D009924:Organ Culture Techniques; D011458:Prostaglandins E / Q000096:biosynthesis*; D012007:Rectum / Q000378:metabolism*; D012460:Sulfasalazine / Q000494:pharmacology
D011458:Prostaglandins E; D012460:Sulfasalazine; D005439:Flufenamic Acid; D008775:Methylprednisolone